Gabriella Ferlazzo

1.2k total citations
25 papers, 428 citations indexed

About

Gabriella Ferlazzo is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Gabriella Ferlazzo has authored 25 papers receiving a total of 428 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Infectious Diseases, 20 papers in Epidemiology and 3 papers in Surgery. Recurrent topics in Gabriella Ferlazzo's work include Tuberculosis Research and Epidemiology (23 papers), Pneumocystis jirovecii pneumonia detection and treatment (11 papers) and Pneumonia and Respiratory Infections (9 papers). Gabriella Ferlazzo is often cited by papers focused on Tuberculosis Research and Epidemiology (23 papers), Pneumocystis jirovecii pneumonia detection and treatment (11 papers) and Pneumonia and Respiratory Infections (9 papers). Gabriella Ferlazzo collaborates with scholars based in South Africa, India and Belgium. Gabriella Ferlazzo's co-authors include Petros Isaakidis, Stobdan Kalon, Homa Mansoor, Erika Mohr-Holland, Jennifer Hughes, Mrinalini Das, Chinmay Laxmeshwar, Jennifer Furin, Helen Cox and Sylvie Jonckheere and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and European Respiratory Journal.

In The Last Decade

Gabriella Ferlazzo

24 papers receiving 415 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gabriella Ferlazzo South Africa 13 388 287 112 44 29 25 428
Anja Reuter South Africa 13 400 1.0× 276 1.0× 114 1.0× 61 1.4× 21 0.7× 31 469
Grania Brigden United States 12 362 0.9× 268 0.9× 119 1.1× 47 1.1× 25 0.9× 21 429
Elize Pietersen South Africa 9 359 0.9× 288 1.0× 126 1.1× 38 0.9× 15 0.5× 13 430
Epifanio Sánchez United States 5 407 1.0× 325 1.1× 156 1.4× 29 0.7× 25 0.9× 5 474
Nargiza Parpieva Uzbekistan 11 379 1.0× 261 0.9× 150 1.3× 36 0.8× 24 0.8× 34 425
Lorenzo Guglielmetti France 14 483 1.2× 457 1.6× 187 1.7× 72 1.6× 19 0.7× 42 653
Zinaida Tigay United Kingdom 8 339 0.9× 249 0.9× 122 1.1× 28 0.6× 23 0.8× 12 372
Lavanya Jayabal India 14 366 0.9× 243 0.8× 86 0.8× 38 0.9× 44 1.5× 37 451
Wânia da Silva Carvalho Brazil 13 297 0.8× 228 0.8× 115 1.0× 26 0.6× 35 1.2× 39 382
Julia Ershova United States 13 409 1.1× 334 1.2× 139 1.2× 42 1.0× 29 1.0× 28 486

Countries citing papers authored by Gabriella Ferlazzo

Since Specialization
Citations

This map shows the geographic impact of Gabriella Ferlazzo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabriella Ferlazzo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabriella Ferlazzo more than expected).

Fields of papers citing papers by Gabriella Ferlazzo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gabriella Ferlazzo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabriella Ferlazzo. The network helps show where Gabriella Ferlazzo may publish in the future.

Co-authorship network of co-authors of Gabriella Ferlazzo

This figure shows the co-authorship network connecting the top 25 collaborators of Gabriella Ferlazzo. A scholar is included among the top collaborators of Gabriella Ferlazzo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gabriella Ferlazzo. Gabriella Ferlazzo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Decroo, Tom, et al.. (2024). Management of rifampicin-resistant tuberculosis in conflict-affected areas: The case of Iraq. PLoS ONE. 19(1). e0296952–e0296952.
2.
Ndlovu, Zibusiso, et al.. (2023). Operationalising targeted next-generation sequencing for routine diagnosis of drug-resistant TB. Public Health Action. 13(2). 43–49. 13 indexed citations
3.
Mansoor, Homa, et al.. (2023). Clinical utility of target-based next-generation sequencing for drug-resistant TB. The International Journal of Tuberculosis and Lung Disease. 27(1). 41–48. 22 indexed citations
4.
Furin, Jennifer, James Mpunga, Tom Ellman, et al.. (2022). TB screening, prevention and treatment cascade in a Malawi prison. The International Journal of Tuberculosis and Lung Disease. 26(10). 956–962. 3 indexed citations
5.
Laxmeshwar, Chinmay, Mrinalini Das, Tom Decroo, et al.. (2022). Psychiatric comorbidities among patients with complex drug-resistant tuberculosis in Mumbai, India. PLoS ONE. 17(2). e0263759–e0263759. 10 indexed citations
6.
Das, Mrinalini, Homa Mansoor, Stobdan Kalon, et al.. (2021). Challenging drug-resistant TB treatment journey for children, adolescents and their care-givers: A qualitative study. PLoS ONE. 16(3). e0248408–e0248408. 22 indexed citations
7.
Das, Mrinalini, Daksha Shah, Homa Mansoor, et al.. (2021). Treatment outcomes of children and adolescents receiving drug-resistant TB treatment in a routine TB programme, Mumbai, India. PLoS ONE. 16(2). e0246639–e0246639. 16 indexed citations
8.
Gupta, Vivek, Pramila Singh, Madhur Verma, et al.. (2020). Yield of Systematic Longitudinal Screening of Household Contacts of Pre-Extensively Drug Resistant (PreXDR) and Extensively Drug Resistant (XDR) Tuberculosis Patients in Mumbai, India. Tropical Medicine and Infectious Disease. 5(2). 83–83. 5 indexed citations
9.
Audibert, Martine, Gabriella Ferlazzo, Joseph Sitienei, et al.. (2020). Cost-effectiveness of diagnostic algorithms including lateral-flow urine lipoarabinomannan for HIV-positive patients with symptoms of tuberculosis. PLoS ONE. 15(1). e0227138–e0227138. 8 indexed citations
10.
Rebello, Letícia C., Homa Mansoor, Stobdan Kalon, et al.. (2020). Adapting TB services during the COVID-19 pandemic in Mumbai, India. The International Journal of Tuberculosis and Lung Disease. 24(10). 1119–1121. 20 indexed citations
11.
Laxmeshwar, Chinmay, Mrinalini Das, Preeti Mehta, et al.. (2020). Routine viral load monitoring and enhanced adherence counselling at a public ART centre in Mumbai, India. PLoS ONE. 15(5). e0232576–e0232576. 19 indexed citations
12.
13.
Nagaraja, Sharath Burugina, Pruthu Thekkur, Homa Mansoor, et al.. (2020). Ambulatory management of pre- and extensively drug resistant tuberculosis patients with imipenem delivered through port-a-cath: A mixed methods study on treatment outcomes and challenges. PLoS ONE. 15(6). e0234651–e0234651. 12 indexed citations
14.
Huerga, Helena, Gabriella Ferlazzo, Stephen Wanjala, et al.. (2019). Mortality in the first six months among HIV-positive and HIV-negative patients empirically treated for tuberculosis. BMC Infectious Diseases. 19(1). 132–132. 6 indexed citations
15.
Ferlazzo, Gabriella, Erika Mohr-Holland, Chinmay Laxmeshwar, et al.. (2018). Early safety and efficacy of the combination of bedaquiline and delamanid for the treatment of patients with drug-resistant tuberculosis in Armenia, India, and South Africa: a retrospective cohort study. The Lancet Infectious Diseases. 18(5). 536–544. 91 indexed citations
16.
Mohr-Holland, Erika, Jennifer Hughes, Anja Reuter, et al.. (2018). Delamanid for rifampicin-resistant tuberculosis: a retrospective study from South Africa. European Respiratory Journal. 51(6). 1800017–1800017. 27 indexed citations
17.
Huerga, Helena, Gabriella Ferlazzo, Paolo Bevilacqua, et al.. (2017). Incremental Yield of Including Determine-TB LAM Assay in Diagnostic Algorithms for Hospitalized and Ambulatory HIV-Positive Patients in Kenya. PLoS ONE. 12(1). e0170976–e0170976. 39 indexed citations
18.
Mohr-Holland, Erika, Johnny Daniels, Odelia Muller, et al.. (2017). Missed opportunities for earlier diagnosis of rifampicin-resistant tuberculosis despite access to Xpert® MTB/RIF. The International Journal of Tuberculosis and Lung Disease. 21(10). 1100–1105. 6 indexed citations
19.
Huerga, Helena, Yolanda Mueller, Gabriella Ferlazzo, et al.. (2015). Implementation and Operational Research. JAIDS Journal of Acquired Immune Deficiency Syndromes. 71(4). e89–e95. 6 indexed citations
20.
Ferlazzo, Gabriella, et al.. (1978). L'età del menarca nella popolazione scolastica di Messina. Messanae Universitas Studiorum (University of Messina). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anja Reuter Breakdown of academic impact, for papers by Grania Brigden Breakdown of academic impact, for papers by Elize Pietersen Breakdown of academic impact, for papers by Epifanio Sánchez Breakdown of academic impact, for papers by Nargiza Parpieva Breakdown of academic impact, for papers by Lorenzo Guglielmetti Breakdown of academic impact, for papers by Zinaida Tigay Breakdown of academic impact, for papers by Lavanya Jayabal Breakdown of academic impact, for papers by Wânia da Silva Carvalho Breakdown of academic impact, for papers by Julia Ershova
Rankless by CCL
2026